Royal Bank of Canada’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $199M | Buy |
|
|||||
|
2025
Q2 | $140M | Buy |
|
|||||
|
2025
Q1 | $91.1M | Buy |
|
|||||
|
2024
Q4 | $73M | Sell |
|
|||||
|
2024
Q3 | $113M | Sell |
|
|||||
|
2024
Q2 | $100M | Buy |
|
|||||
|
2024
Q1 | $56M | Buy |
|
|||||
|
2023
Q4 | $49.4M | Buy |
|
|||||
|
2023
Q3 | $43.2M | Sell |
|
|||||
|
2023
Q2 | $46.8M | Buy |
|
|||||
|
2023
Q1 | $43.3M | Buy |
|
|||||
|
2022
Q4 | $46.7M | Buy |
|
|||||
|
2022
Q3 | $13.2M | Sell |
|
|||||
|
2022
Q2 | $11.8M | Buy |
|
|||||
|
2022
Q1 | $3.69M | Sell |
|
|||||
|
2021
Q4 | $4.78M | Buy |
|
|||||
|
2021
Q3 | $4.64M | Buy |
|
|||||
|
2021
Q2 | $2.73M | Sell |
|
|||||
|
2021
Q1 | $2.29M | Sell |
|
|||||
|
2020
Q4 | $3.84M | Buy |
|
|||||
|
2020
Q3 | $2.85M | Sell |
|
|||||
|
2020
Q2 | $3.52M | Buy |
|
|||||
|
2020
Q1 | $2.49M | Buy |
|
|||||
|
2019
Q4 | $2.34M | Sell |
|
|||||
|
2019
Q3 | $2.9M | Sell |
|
|||||
|
2019
Q2 | $2.92M | Buy |
|
|||||
|
2019
Q1 | $1.28M | Buy |
|
|||||
|
2018
Q4 | $835K | Buy |
|
|||||
|
2018
Q3 | $888K | Buy |
|
|||||
|
2018
Q2 | $703K | Buy |
|
|||||
|
2018
Q1 | $651K | Buy |
|
|||||
|
2017
Q4 | $341K | Buy |
|
|||||
|
2017
Q3 | $207K | Buy |
|
|||||
|
2017
Q2 | $118K | Sell |
|
|||||
|
2017
Q1 | $274K | Buy |
|
|||||
|
2016
Q4 | $128K | Sell |
|
|||||
|
2016
Q3 | $3.91M | Buy |
|
|||||
|
2016
Q2 | $2.85M | Buy |
|
|||||
|
2016
Q1 | $1.98M | Buy |
|
|||||
|
2015
Q4 | $2.46M | Buy |
|
|||||
|
2015
Q3 | $982K | Sell |
|
|||||
|
2015
Q2 | $1.52M | Sell |
|
|||||
|
2015
Q1 | $1.82M | Buy |
|
|||||
|
2014
Q4 | $759K | Sell |
|
|||||
|
2014
Q3 | $1.89M | Buy |
|
|||||
|
2014
Q2 | $490K | Buy |
|
|||||
|
2014
Q1 | $84K | Sell |
|
|||||
|
2013
Q4 | $214K | Sell |
|
|||||
|
2013
Q3 | $334K | Buy |
|
|||||
|
2013
Q2 | $109K | Buy |
|